Bullfrog AI (BFRG) Competitors $1.27 +0.07 (+5.83%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.26 -0.01 (-0.79%) As of 08/22/2025 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. LTRN, KALA, VTVT, ALGS, ATHE, KLRS, BRNS, TELO, GRCE, and GANXShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Lantern Pharma (LTRN), KALA BIO (KALA), vTv Therapeutics (VTVT), Aligos Therapeutics (ALGS), Alterity Therapeutics (ATHE), Kalaris Therapeutics (KLRS), Barinthus Biotherapeutics (BRNS), Telomir Pharmaceuticals (TELO), Grace Therapeutics (GRCE), and Gain Therapeutics (GANX). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors Lantern Pharma KALA BIO vTv Therapeutics Aligos Therapeutics Alterity Therapeutics Kalaris Therapeutics Barinthus Biotherapeutics Telomir Pharmaceuticals Grace Therapeutics Gain Therapeutics Bullfrog AI (NASDAQ:BFRG) and Lantern Pharma (NASDAQ:LTRN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Do analysts rate BFRG or LTRN? Lantern Pharma has a consensus target price of $25.00, indicating a potential upside of 454.32%. Given Lantern Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Lantern Pharma is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lantern Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BFRG or LTRN more profitable? Lantern Pharma's return on equity of -99.89% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -195.35% -162.37% Lantern Pharma N/A -99.89%-81.58% Which has more volatility and risk, BFRG or LTRN? Bullfrog AI has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Lantern Pharma has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Does the media refer more to BFRG or LTRN? In the previous week, Lantern Pharma had 2 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for Lantern Pharma and 0 mentions for Bullfrog AI. Lantern Pharma's average media sentiment score of 0.17 beat Bullfrog AI's score of 0.00 indicating that Lantern Pharma is being referred to more favorably in the news media. Company Overall Sentiment Bullfrog AI Neutral Lantern Pharma Neutral Do insiders & institutionals believe in BFRG or LTRN? 1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 28.6% of Lantern Pharma shares are owned by institutional investors. 24.7% of Bullfrog AI shares are owned by insiders. Comparatively, 8.5% of Lantern Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, BFRG or LTRN? Bullfrog AI has higher revenue and earnings than Lantern Pharma. Lantern Pharma is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K213.36-$6.99M-$0.76-1.67Lantern PharmaN/AN/A-$20.78M-$1.78-2.53 SummaryLantern Pharma beats Bullfrog AI on 9 of the 14 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.10M$2.05B$5.75B$9.62BDividend YieldN/AN/A4.40%4.10%P/E Ratio-1.6738.6631.3026.05Price / Sales213.369.88432.98193.75Price / CashN/A51.9937.7358.48Price / Book5.776.709.536.61Net Income-$6.99M-$63.67M$3.26B$265.65M7 Day Performance1.60%4.61%2.13%2.02%1 Month Performance-18.06%0.23%2.80%-0.31%1 Year Performance-50.39%26.48%30.68%19.06% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.407 of 5 stars$1.27+5.8%N/A-53.0%$12.10M$60K-1.674LTRNLantern Pharma2.6613 of 5 stars$4.40+1.5%$25.00+468.7%+6.9%$47.39MN/A-2.3920KALAKALA BIO4.1275 of 5 stars$7.34+1.9%$13.00+77.1%+57.2%$47.34M$3.89M-1.0830VTVTvTv Therapeutics1.5897 of 5 stars$14.73+5.2%$35.50+141.0%-8.4%$46.99M$1.02M-4.899Gap DownALGSAligos Therapeutics4.5605 of 5 stars$7.68+1.5%$70.00+811.5%-26.3%$46.93M$3.94M-0.3990Positive NewsAnalyst RevisionATHEAlterity Therapeutics2.205 of 5 stars$5.28-0.8%$12.00+127.3%+280.3%$46.83MN/A0.0010KLRSKalaris Therapeutics1.2835 of 5 stars$2.50-6.0%$3.00+20.0%N/A$46.75MN/A0.00110Gap DownBRNSBarinthus Biotherapeutics3.2125 of 5 stars$1.15+0.9%$6.25+443.5%-4.8%$46.39M$14.97M-0.66107Positive NewsShort Interest ↑Gap UpTELOTelomir Pharmaceuticals2.6734 of 5 stars$1.55-1.9%$15.00+867.7%-74.4%$46.13MN/A-3.691Gap DownGRCEGrace Therapeutics2.8154 of 5 stars$3.30+6.5%$12.00+263.6%N/A$45.64MN/A-3.71N/AAnalyst UpgradeGANXGain Therapeutics2.5658 of 5 stars$1.52+3.8%$8.20+441.3%+50.4%$45.56M$50K-1.7620Positive News Related Companies and Tools Related Companies Lantern Pharma Competitors KALA BIO Competitors vTv Therapeutics Competitors Aligos Therapeutics Competitors Alterity Therapeutics Competitors Kalaris Therapeutics Competitors Barinthus Biotherapeutics Competitors Telomir Pharmaceuticals Competitors Grace Therapeutics Competitors Gain Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access